Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Censoring Survival Data01:09

Censoring Survival Data

56
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
56
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

78
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
78
Prediction Intervals01:03

Prediction Intervals

2.2K
The interval estimate of any variable is known as the prediction interval. It helps decide if a point estimate is dependable.
However, the point estimate is most likely not the exact value of the population parameter, but close to it. After calculating point estimates, we construct interval estimates, called confidence intervals or prediction intervals. This prediction interval comprises a range of values unlike the point estimate and is a better predictor of the observed sample value, y. 
2.2K
Truncation in Survival Analysis01:09

Truncation in Survival Analysis

145
Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
145
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

24
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
24
Bootstrapping01:24

Bootstrapping

576
The term "bootstrap" originated in the 19th century as a metaphor for self-improvement or achieving something independently, without external assistance. This concept extends to statistical bootstrapping, a self-contained method for estimating population parameters through resampling, even though it can be computationally intensive. Developed by the American statistician Dr. Bradley Efron in 1979, bootstrapping provides a robust way to perform inference when the original sample size is...
576

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AAV mini-dystrophin gene therapy for Duchenne muscular dystrophy: a phase 1b trial.

Nature medicine·2025
Same author

Cardiovascular and Renal Outcomes with Ertugliflozin by Baseline Use of Renin-Angiotensin-Aldosterone System Inhibitors or Diuretics, Including Mineralocorticoid Receptor Antagonist: Analyses from the VERTIS CV Trial.

Kidney diseases (Basel, Switzerland)·2025
Same author

Heart failure outcomes captured by adverse event reporting in participants with type 2 diabetes and atherosclerotic cardiovascular disease: Observations from the VERTIS CV trial.

European journal of heart failure·2025
Same author

Long-term weight loss and cardiorenal outcomes by baseline BMI in the VERTIS CV trial.

Diabetes, obesity & metabolism·2024
Same author

Effects of ertugliflozin on uric acid and gout-related outcomes in persons with type 2 diabetes and cardiovascular disease: Post hoc analyses from VERTIS CV.

Diabetes, obesity & metabolism·2024
Same author

Ertugliflozin and hospitalization for heart failure across the spectrum of pre-trial ejection fraction: post-hoc analyses of the VERTIS CV trial.

European heart journal·2023
Same journal

Methods for incorporating test result information within the high-dimensional propensity score framework: application in UK electronic health record data.

BMC medical research methodology·2026
Same journal

Sparse multi-way DMDC for longitudinal classification in high dimension low sample size data.

BMC medical research methodology·2026
Same journal

Tree-based exploratory identification of predictive biomarkers in non-randomized data.

BMC medical research methodology·2026
Same journal

Comparative evaluation of interrupted time series analytical methods for healthcare quality improvement research: a Monte Carlo simulation study.

BMC medical research methodology·2026
Same journal

Methodological advances in claims-based dementia algorithms: integrating medication and clinical data for medicare populations.

BMC medical research methodology·2026
Same journal

An interpretable XGboost algorithm for predicting 30-day mortality in acute pancreatitis using routine biomarkers.

BMC medical research methodology·2026
See all related articles

Related Experiment Video

Updated: May 26, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.3K

Comprehensive implementations of multiple imputation using retrieved dropouts for continuous endpoints.

Shuai Wang1, Pamela F Schwartz2, James P Mancuso2

  • 1Pfizer Research & Development, Pfizer Inc, New York, NY, USA. shuai1107@hotmail.com.

BMC Medical Research Methodology
|February 21, 2025
PubMed
Summary
This summary is machine-generated.

A new multiple imputation based on retrieved dropouts (MIRD) approach using all available data from dropouts offers comparable performance to established methods for longitudinal data analysis in metabolic diseases. This method, particularly the one-step MCMC, shows improved power and type-I error control in certain scenarios, simplifying clinical trial reporting.

Keywords:
Chronic weight managementMultiple imputationPhase 3 clinical trialsRetrieved dropoutsTreatment policy estimandType 2 diabetes

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.6K

Related Experiment Videos

Last Updated: May 26, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.3K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.6K

Area of Science:

  • Biostatistics
  • Longitudinal Data Analysis
  • Metabolic Disease Research

Background:

  • Mixed Models for Repeated Measures (MMRM) face challenges with missing data in metabolic diseases.
  • Multiple Imputation based on Retrieved Dropouts (MIRD) is emerging as a standard for longitudinal endpoints.
  • Existing MIRD methods often rely on last on-treatment data for imputation.

Purpose of the Study:

  • To introduce and evaluate a novel class of MIRD approaches utilizing all available data from retrieved dropouts (RDs).
  • To compare the performance of new MIRD methods against established MIRD and other statistical approaches like MMRM.
  • To assess type-I error and power rates under various missing data scenarios.

Main Methods:

  • Proposed new MIRD methods using all available RD data, implemented via one-step MCMC or two-step regression.
  • Applied ANCOVA post-imputation and Rubin's rule for combining estimates.
  • Conducted extensive simulation studies and analyzed two real-world Phase 3 clinical trial datasets.

Main Results:

  • The new MIRD class demonstrated performance comparable to the established MIRD approach.
  • The one-step MCMC MIRD method showed better type-I error control and increased power in specific scenarios.
  • Real-world data analysis confirmed the enhanced power of the new MIRD class, especially in larger datasets.

Conclusions:

  • The proposed MIRD approach using all observed RD data is a robust and powerful alternative for longitudinal continuous endpoints.
  • The one-step MCMC implementation offers advantages in statistical power and type-I error control.
  • This new MIRD class is anticipated to be more easily implemented in clinical trial reporting due to simpler programming.